Folate-conjugated nanoparticles as a potent therapeutic approach in targeted cancer therapy

The selective and efficient drug delivery to tumor cells can remarkably improve different cancer therapeutic approaches. There are several nanoparticles (NPs) which can act as a potent drug carrier for cancer therapy. However, the specific drug delivery to cancer cells is an important issue which should be considered before designing new NPs for in vivo application. It has been shown that cancer cells over-express folate receptor (FR) in order to improve their growth. As normal cells express a significantly lower levels of FR compared to tumor cells, it seems that folate molecules can be used as potent targeting moieties in different nanocarrier-based therapeutic approaches. Moreover, there is evidence which implies folate-conjugated NPs can selectively deliver anti-tumor drugs into cancer cells both in vitro and in vivo. In this review, we will discuss about the efficiency of different folate-conjugated NPs in cancer therapy. © 2015, International Society of Oncology and BioMarkers (ISOBM)

Multiscale modelling of ceramic nanoparticle interactions and their influence on the thermal conductivity of nanofluids

There is currently a lack of a reliable theory capable of making accurate predictions of the thermal enhancement in nanofluids (with relatively low solid volume fractions). The work described therefore assesses the thermal conductivity of nanoparticle suspensions in fluids using a Lagrangian particle tracking-based computational modelling technique. A 3D, multiphase fluid-solid model is developed which predicts the motion of suspended nanoparticles. The nanofluid is predicted using an Eulerian-Lagrangian hybrid approach with a constant timestep. This technique takes various multiscale forces into consideration in the calculations, whose characteristic scales are quite different, providing for the first time an analysis of all factors affecting the stability and thermal conductivity of nanofluids. The system considered consists of 71 nm diameter Al2O3 ceramic nanoparticles suspended in water, with homogeneous temperature distributions ranging from 25 °C to 85 °C, at various volume fractions between 1% and 5%. The results of the simulations demonstrate the effectiveness of the presented technique, with predictions elucidating the role of Brownian motion, fluid viscous drag, inter-particle collisions and DLVO attraction and repulsion forces on nanofluid stability. Results indicate that aggregated nanoparticles formed in the suspensions, at various particle concentrations, play an important role in the thermal behaviour of the nanofluids. Predictions are in agreement with theoretical and experimental results obtained in related studies. The thermal characteristics of nanofluids are also considered as a function of temperature, system chemistry and time (measured from an initially homogeneously dispersed state). The proven enhancement in the conductivity of fluids affected by the addition of nanoparticles has great potential to assist the development of commercial nanofluid technology aimed at energy efficient and sustainable processes

Ibrutinib-A double-edge sword in cancer and autoimmune disorders

Targeted therapies have appeared as new treatment options for several disease types, including cancer and autoimmune disorders. Of several targets, tyrosine kinases (TKs) are among the most promising. Overexpression of TKs provides a target for novel therapeutic agents, including small molecule inhibitors of tyrosine kinases (TKI). Ibrutinib (PCI-32765) is a TKI of Bruton’s tyrosine kinase (Btk), a key kinase of the B-cell receptor signaling pathway that plays a significant role in the proliferation, differentiation and survival of B cells. In addition to inhibitory effects, recent studies have shown that ibrutinib has multiple immunomodulatory effects. It binds covalently to IL-2 inducible tyrosine kinase (Itk) in T lymphocytes and suppresses the survival of T-helper (Th) 2 cells. This changes the balance of Th1/Th2 cells toward Th1 subset, which are the main immune cells targeting tumor cells. The dual activity of ibrutinib has paid a great attention and several studies are evaluating the anti-tumor and immunomodulatory effects in cancer, autoimmune disorders and infectious diseases. In this article we review the inhibitory and immunomodulatory effects of ibrutinib in B-cell malignancies, autoimmune diseases and infections, as well as the communication between the Ror1 receptor tyrosine kinase and BCR and effects of ibrutinib on this crosstalk.CLL Global Research FoundationManuscrip

Boundary layer flow of nanofluid over an exponentially stretching surface

The steady boundary layer flow of nanofluid over an exponential stretching surface is investigated analytically. The transport equations include the effects of Brownian motion parameter and thermophoresis parameter. The highly nonlinear coupled partial differential equations are simplified with the help of suitable similarity transformations. The reduced equations are then solved analytically with the help of homotopy analysis method (HAM). The convergence of HAM solutions are obtained by plotting h-curve. The expressions for velocity, temperature and nanoparticle volume fraction are computed for some values of the parameters namely, suction injection parameter α, Lewis number Le, the Brownian motion parameter Nb and thermophoresis parameter Nt